Multimodal tumor suppression by METTL3 gene knockdown in melanoma and colon cancer cells
Authors:
- 25 December 2024
- journal article
- research article
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 163 (1) , 1-11
Abstract
METTL3, an m6A methyltransferase, is integral to the regulation of messenger RNA (mRNA) biogenesis, degradation, and translation through the N6-methyladenosine (m6A) modification. Alterations in m6A homeostasis have been implicated in the development, progression, invasion, and metastasis of certain cancers. The present research aims to examine the consequences of METTL3 knockdown using short hairpin RNA (shRNA) on the proliferation and invasive capabilities of human colorectal and melanoma cancer cell lines. A specific shRNA against METTL3 mRNA was designed and inserted into an expression vector. Highly invasive colorectal cancer cell line SW480 and melanoma cell line A375 were cultured and transfected by METTL3-shRNA and scramble-control vectors and kept under culture condition for 2 weeks. The cells were harvested for analysis of gene expression by quantitative polymerase chain reaction (qPCR), invasion assay using three-dimensional (3D) spheroid assay and cell cycle and apoptosis analyses. In the METTL3-shRNA transfected cells, the expression of METTL3, VIM, SNAI1, SNAI2, ZEB1, CDH1, and TGFB1 genes were downregulated significantly compared with the scramble-control transfected cells. Expression of b-catenin, N-cadherin, vimentin, ZEB1, pro- and active MMP2, OCT4A, SOX2, and MYC proteins were also downregulated following METTL3 knockdown. Transfection by METTL3-shRNA reduced proliferation rate of the cells and increased the apoptotic rate significantly. Both migration and invasion rate of the cancer cells transfected with METTL3-shRNA were significantly decreased. These findings highlight the pro-oncogenic function of METTL3 in colorectal and melanoma cancer cells, indicating that inhibiting METTL3 could be a promising approach for tumor suppression across multiple cancer types; nonetheless, further investigation is essential to confirm these observations.Keywords
All Related Versions
Funding Information
- National Institute of Genetic Engineering and Biotechnology (981101-I-760)
This publication has 52 references indexed in Scilit:
- The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progressionBiomedicine & Pharmacotherapy, 2020
- RNA m6A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c‐MetJournal of Cellular Physiology, 2020
- N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancerEBioMedicine, 2019
- Functions of RNA N6-methyladenosine modification in cancer progressionMolecular Biology Reports, 2019
- RNA m6A modification and its function in diseasesFrontiers of Medicine, 2018
- Roles of RNA methylation by means of N6-methyladenosine (m6A) in human cancersCancer Letters, 2017
- m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem CellsCell Reports, 2017
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor MetastasisDevelopmental Cell, 2008
- Drosophila U6 promoter-driven short hairpin RNAs effectively induce RNA interference in Schneider 2 cellsBiochemical and Biophysical Research Communications, 2005